Neuland to set up $20m process development facility in Hyderabad

New facility will open by October 2026 and house 500 process development specialists

Sygnature Discovery partners with DaltonTx to enhance AI-driven drug discovery capabilities

Collaboration aims to accelerate medicinal chemistry decision-making, reduce synthesis burden and strengthen data-secure AI adoption in drug discovery

Symeres expands spray drying capabilities to accelerate small-molecule drug development in New Jersey

Enhanced CMC infrastructure at Cranbury site aims to improve bioavailability, streamline formulation development and support faster progression of challenging drug candidates into clinical trials

GSK bets big on oncology with $10.6 billion Nuvalent acquisition

Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio

Axplora consolidates global UDCA manufacturing at Vizag facility

Strategic shift from Italy to India strengthens supply chain resilience, expands capacity and enhances sustainability for the growing global UDCA market

Merck appoints Clara Sattler de Sousa e Brito and Robert Machinek to key leadership roles

Clara Sattler de Sousa e Brito to lead discovery solutions from Q3 2026, while Robert Machinek takes over as Head of Strategy & Business Development

Our vision is to make genomics as commonplace as BP monitor: Dr. Ramesh Hariharan, Chief Executive Officer, Strand Life Sciences

We are building the bridge between complex molecular data and everyday clinical decisions

TDB supports Indigenous production of green pharma ingredients

Chennai based Bioneemtec India has received support from Technology Development Board for commercializing indigenous green chemistry technologies to produce critical pharmaceutical ingredients

Aragen Life Sciences elevates Pavan Kumar Kamarajugadda to Senior Director

Ardena appoints Ariane de Ganck as Chief Scientific Officer

Ariane brings a strong track record within Ardena, including her leadership of the company’s drug product division since 2022